Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
42,079,879
-
Total 13F shares
-
8,762,240
-
Share change
-
+707,989
-
Total reported value
-
$28,676,783
-
Price per share
-
$3.27
-
Number of holders
-
25
-
Value change
-
+$2,327,230
-
Number of buys
-
10
-
Number of sells
-
3
Institutional Holders of InspireMD, Inc. - Common Stock, $0.0001 par value (NSPR) as of Q3 2023
As of 30 Sep 2023,
InspireMD, Inc. - Common Stock, $0.0001 par value (NSPR) was held by
25 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,762,240 shares.
The largest 10 holders included
MARSHALL WACE, LLP, ORBIMED ADVISORS LLC, Nantahala Capital Management, LLC, Soleus Capital Management, L.P., Velan Capital Investment Management LP, PURA VIDA INVESTMENTS, LLC, Point72 Asset Management, L.P., MILLENNIUM MANAGEMENT LLC, MORGAN STANLEY, and HighTower Advisors, LLC.
This page lists
25
institutional shareholders reporting positions in this security
for the Q3 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.